The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Chemical chaperones mediate increased secretion of mutant α1-antitrypsin (α1-AT) Z: A potential pharmacological strategy for prevention of liver injury and emphysema in α1-AT deficiency
Open accessAbstract
In α1-AT deficiency, a misfolded but functionally active mutant α1-ATZ (α1-ATZ) molecule is retained in the endoplasmic reticulum of liver cells rather than secreted into the blood and body fluids. Emphysema is thought to be caused by the lack of circulating α1-AT to inhibit neutrophil elastase in the lung. Liver injury is thought to be caused by the hepatotoxic effects of the retained α1-ATZ. In this study, we show that several “chemical chaperones,” which have been shown to reverse the cellular mislocalization or misfolding of other mutant plasma membrane, nuclear, and cytoplasmic proteins, mediate increased secretion of α1-ATZ. In particular, 4-phenylbutyric acid (PBA) mediated a marked increase in secretion of functionally active α1-ATZ in a model cell culture system. Moreover, oral administration of PBA was well tolerated by PiZ mice (transgenic for the human α1-ATZ gene) and consistently mediated an increase in blood levels of human α1-AT reaching 20–50% of the levels present in PiM mice and normal humans. Because clinical studies have suggested that only partial correction is needed for prevention of both liver and lung injury in α1-AT deficiency and PBA has been used safely in humans, it constitutes an excellent candidate for chemoprophylaxis of target organ injury in α1-AT deficiency.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The mechanism of Z α1-antitrypsin accumulation in the liver
Lomas, D. A., LI-Evans, D., Finch, J. T., & Carrell, R. W. (1992) · Nature · doi:10.1038/357605a0 · Cited by 1,053
Carrell, R. W., & Lomas, D. A. (1997) · The Lancet · doi:10.1016/s0140-6736(97)02073-4 · Cited by 807
Fan, J.-Q., Ishii, S., Asano, N., & Suzuki, Y. (1999) · Nature Medicine · doi:10.1038/4801 · Cited by 614
Risk of Cirrhosis and Primary Liver Cancer in Alpha1-Antitrypsin Deficiency
Eriksson, S., Carlson, J., & Velez, R. (1986) · New England Journal of Medicine · doi:10.1056/nejm198603203141202 · Cited by 580
Glycerol Reverses the Misfolding Phenotype of the Most Common Cystic Fibrosis Mutation
Sato, S., Ward, C. L., Krouse, M. E., Wine, J. J., & Kopito, R. R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.2.635 · Cited by 519
Crystal, R. G. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114578 · Cited by 495
Rubenstein, R. C., Egan, M. E., & Zeitlin, P. L. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119788 · Cited by 389
Qu, D., Teckman, J. H., Omura, S., & Perlmutter, D. H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.37.22791 · Cited by 366
Self-citationRUBENSTEIN, R. C., & ZEITLIN, P. L. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.2.9706088 · Cited by 340
Tamarappoo, B. K., & Verkman, A. S. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2303 · Cited by 329
Accumulation of PiZ alpha 1-antitrypsin causes liver damage in transgenic mice.
Carlson, J. A., Rogers, B. B., Sifers, R. N., Finegold, M. J., Clift, S. M., DeMayo, F. J., Bullock, D. W., & Woo, S. L. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113999 · Cited by 329
Chemical chaperones interfere with the formation of scrapie prion protein.
Tatzelt, J., Prusiner, S. B., & Welch, W. J. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01027.x · Cited by 294
Wu, Y., Whitman, I., Molmenti, E., Moore, K., Hippenmeyer, P., & Perlmutter, D. H. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.9014 · Cited by 290
Self-citationOgushi, F., Fells, G. A., Hubbard, R. C., Straus, S. D., & Crystal, R. G. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113214 · Cited by 217
Heteropolymerization of S, I, and Z α1-antitrypsin and liver cirrhosis
Mahadeva, R., Chang, W.-S. W., Dafforn, T. R., Oakley, D. J., Foreman, R. C., Calvin, J., Wight, D. G. D., & Lomas, D. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci4874 · Cited by 191
Correcting temperature-sensitive protein folding defects
Brown, C. R., Hong-Brown, L. Q., & Welch, W. J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119302 · Cited by 176
Phenylacetylglutamine May Replace Urea as a Vehicle for Waste Nitrogen Excretion
Brusilow, S. W. (1991) · Pediatric Research · doi:10.1203/00006450-199102000-00009 · Cited by 169
Prospective treatment of urea cycle disorders
Maestri, N. E., Hauser, E. R., Bartholomew, D., & Brusilow, S. W. (1991) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)83044-6 · Cited by 146
Campbell, E. J., Campbell, M. A., Boukedes, S. S., & Owen, C. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6092 · Cited by 138
Bathurst, I., Travis, J. W., George, P. M., & Carrell, R. W. (1984) · FEBS Letters · doi:10.1016/0014-5793(84)81279-x · Cited by 74
Cited by
Özcan, U., Yilmaz, E., Özcan, L., Furuhashi, M., Vaillancourt, E., Smith, R. O., Görgün, C. Z., & Hotamisligil, G. S. (2006) · Science · doi:10.1126/science.1128294 · Cited by 2,413
Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities
Kim, I., Xu, W., & Reed, J. C. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2755 · Cited by 1,817
Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809
Van Goor, F., Hadida, S., Grootenhuis, P. D. J., Burton, B., Stack, J. H., Straley, K. S., Decker, C. J., Miller, M., McCartney, J., Olson, E. R., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105787108 · Cited by 1,088
A Mutation in the Surfactant Protein C Gene Associated with Familial Interstitial Lung Disease
Nogee, L. M., Dunbar, A. E., Wert, S. E., Askin, F., Hamvas, A., & Whitsett, J. A. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102223440805 · Cited by 929
(2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.168.7.818 · Cited by 911
Metadata
- Authors
- Burrows, J. A. J., Willis, L. K., & Perlmutter, D. H.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2000-02-15
- Volume
- 97
- Issue
- 4
- Pages
- 1796-1801
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2054159211
- Cited by
- 426
- References
- 20
- FWCI
- 6.20
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.